|
|
| General Information |
Laser Refractive Surgery | Cataract Surgery |
Inflammatory Eye Disease |
Macular Degeneration |
Macular Degeneration
Age-related Macular Degeneration (ARMD) is a disorder of the central visual area of the retina known as the macula. It usually affects elderly people and occasionally runs in families. There are two types of ARMD:
- A geographical or
dry form that is
usually only slowly
progressive; and- An exudative or wet
form that can rapidly
result in worsening
vision.As it is a disorder of the central vision, patients with ARMD have difficulty reading and performing fine detailed tasks. As the disease progresses, they may have difficulty seeing faces. Usually, most patients maintain peripheral vision.
In the wet type of macular degeneration, new blood vessels grow under the macula. These can leak blood and fluid and lead to deterioration of vision and eventually scar tissue.
Treatment for Wet Macular Degeneration
Lucentis is a drug approved for the treatment of wet macular degeneration. This drug blocks the molecule VEGF (vasoactive endothelial growth factor) that promotes wet ARMD. Lucentis is administered by intraocular injection. A series of treatments is usually required to stabilise or improve the vision.
For a consultation, diagnosis and further advice on Macular Degeneration, please contact your GP and ask for a referral to Conrad Eye Care - Dr Diana Conrad.
